Answers are grounded in this paper and cite their sources.
Since hyperuricemia is a risk factor for cardiovascular disease and chronic kidney disease, it is necessary to pay attention to trends in uric acid levels when treating hypertensive patients with drugs. The present study investigated the effect of switching from angiotensin II receptor blocker (ARB) to sacubitril/valsartan on serum uric acid levels in treated hypertensive patients and further examined what factors could be associated with its effect.
No takes yet. Share an insight, caveat, or question.
Horio et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: